Gene sequencing is like a double-edged sword. If used improperly, it also has a negative side. If the whole gene testing is popular, once the information of the genetic defect person falls into the hands of the tested employer, it will have a negative impact on their lives.
Moreover, the uncertainty of gene sequencing is the only basis of individualized therapy, and others include other technical foundations such as gene therapy. More importantly, for any gene sequencing equipment, before clinical use, it is necessary to do a complete clinical trial on its reliability and repeatability, and obtain the authoritative certification of FDA and CFDA.